L & S Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Buy |
14,810
+1,706
| +13% | +$608K | 0.66% | 46 |
|
|
2025
Q4 | $4.29M | Buy |
+13,104
| New | +$4.16M | 0.4% | 75 |
|
|
2024
Q4 | – | Sell |
-10,774
| Closed | -$3.47M | – | 337 |
|
|
2024
Q3 | $3.47M | Sell |
10,774
-9,316
| -46% | -$3.05M | 0.36% | 79 |
|
|
2024
Q2 | $6.28M | Buy |
20,090
+9,291
| +86% | +$2.73M | 0.72% | 39 |
|
|
2024
Q1 | $3.07M | Sell |
10,799
-8,133
| -43% | -$2.38M | 0.35% | 87 |
|
|
2023
Q4 | $5.45M | Sell |
18,932
-1,214
| -6% | -$331K | 0.66% | 53 |
|
|
2023
Q3 | $5.41M | Buy |
+20,146
| New | +$5.03M | 0.78% | 39 |
|
|
2023
Q1 | – | Sell |
-18,632
| Closed | -$4.89M | – | 303 |
|
|
2022
Q4 | $4.89M | Sell |
18,632
-6,635
| -26% | -$1.78M | 0.91% | 39 |
|
|
2022
Q3 | $5.7M | Buy |
25,267
+328
| +1% | +$79.5K | 1% | 28 |
|
|
2022
Q2 | $6.07M | Buy |
24,939
+11,379
| +84% | +$2.79M | 1.01% | 25 |
|
|
2022
Q1 | $3.28M | Buy |
13,560
+1,690
| +14% | +$388K | 0.39% | 73 |
|
|
2021
Q4 | $2.67M | Buy |
11,870
+10,662
| +883% | +$2.25M | 0.29% | 104 |
|
|
2021
Q3 | $257K | Sell |
1,208
-75
| -6% | -$17.3K | 0.03% | 305 |
|
|
2021
Q2 | $313K | Sell |
1,283
-240
| -16% | -$59K | 0.03% | 275 |
|
|
2021
Q1 | $379K | Hold |
1,523
| – | – | 0.04% | 275 |
|
|
2020
Q4 | $350K | Buy |
1,523
+50
| +3% | +$11.5K | 0.04% | 268 |
|
|
2020
Q3 | $374K | Buy |
1,473
+38
| +3% | +$9.41K | 0.05% | 242 |
|
|
2020
Q2 | $338K | Sell |
1,435
-25,408
| -95% | -$5.8M | 0.05% | 251 |
|
|
2020
Q1 | $5.44M | Sell |
26,843
-11,407
| -30% | -$2.49M | 1.03% | 23 |
|
|
2019
Q4 | $9.22M | Buy |
38,250
+7,270
| +23% | +$1.6M | 1.18% | 19 |
|
|
2019
Q3 | $6M | Buy |
30,980
+23,938
| +340% | +$4.59M | 0.84% | 32 |
|
|
2019
Q2 | $1.3M | Sell |
7,042
-105
| -1% | -$18.8K | 0.17% | 143 |
|
|
2019
Q1 | $1.36M | Sell |
7,147
-20,430
| -74% | -$3.9M | 0.18% | 121 |
|
|
2018
Q4 | $5.37M | Sell |
27,577
-3,946
| -13% | -$770K | 1.01% | 23 |
|
|
2018
Q3 | $6.53M | Buy |
+31,523
| New | +$6.21M | 0.85% | 35 |
|
|
2017
Q4 | – | Sell |
-14,721
| Closed | -$2.75M | – | 311 |
|
|
2017
Q3 | $2.75M | Buy |
+14,721
| New | +$2.61M | 0.46% | 67 |
|
|
2017
Q2 | – | Sell |
-25,448
| Closed | -$4.17M | – | 291 |
|
|
2017
Q1 | $4.17M | Buy |
25,448
+24,021
| +1,683% | +$3.99M | 0.8% | 31 |
|
|
2016
Q4 | $209K | Sell |
1,427
-42,415
| -97% | -$6.38M | 0.05% | 156 |
|
|
2016
Q3 | $7.31M | Sell |
43,842
-2,943
| -6% | -$498K | 2.02% | 9 |
|
|
2016
Q2 | $7.12M | Buy |
+46,785
| New | +$7.27M | 1.62% | 25 |
|
|
2016
Q1 | – | Sell |
-37,726
| Closed | -$6.12M | – | 76 |
|
|
2015
Q4 | $6.12M | Buy |
37,726
+10,916
| +41% | +$1.72M | 1.53% | 21 |
|
|
2015
Q3 | $3.71M | Buy |
+26,810
| New | +$4.23M | 1.08% | 40 |
|
|
2014
Q2 | – | Sell |
-17,270
| Closed | -$2.13M | – | 84 |
|
|
2014
Q1 | $2.13M | Buy |
+17,270
| New | +$2.09M | 1.14% | 21 |
|
Other funds holding AMGN
VCM
VPM
L & S Advisors's AMGN Position: Q1 2026 in Review
L & S Advisors increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $608K and bringing the position to 14,810 shares worth $5.21M. The position accounts for 0.66% of the portfolio, ranked #46.
L & S Advisors first reported a position in AMGN in Q1 2014 and has held it in 33 quarters since. The position peaked at $9.22M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- L & S Advisors held 14,810 shares of Amgen worth $5.21M as of Q1 2026.
- L & S Advisors bought 1,706 Amgen shares in Q1 2026, an estimated $608K.
- Amgen made up 0.66% of L & S Advisors's portfolio in Q1 2026, its #46 holding.
- L & S Advisors first reported a position in Amgen in Q1 2014 and has held it in 33 quarters since.
- L & S Advisors's Amgen position peaked at $9.22M in Q4 2019.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on L & S Advisors's 13F filing for Q1 2026, filed 11 May 2026.